|
|
|
|
Elutia Inc (NASDAQ: ELUT) |
|
|
|
|
|
Elutia Inc's Suppliers Performance
ELUT's Supply Chain
| |
|
ELUT Costs vs Sales of Suppliers Growth |
Elutia Inc's cost of sales deteriorated by 0 % year on year, relative to one quarter ago cost of sales fell by -25 % in Q1.
•
More on ELUT Suppliers
|
|
|
Elutia Inc's cost of sales deteriorated by 0 % year on year, compare to one quarter ago cost of sales fell by -25 % in Q1.
•
More on ELUT Suppliers
|
Select the Relationship:
|
|
Select the Category:
|
|
Elutia Inc's Comment on Supply Chain
ELUT's vs. Suppliers, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
| COMPANY NAME |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
|
Elutia Inc
|
76.81 |
23.32 |
-39.89 |
- |
| SUBTOTAL |
0.00 |
0.00 |
0.00 |
- |
News about
Elutia Inc Contracts
|
Elutia, a foremost innovator in the field of cardiac medical devices, has marked a historic milestone with the FDA clearance of its latest advancement, EluPro. This pioneering product, touted as the first antibiotic-eluting bioEnvelope, is designed to offer unparalleled protection for patients with implantable cardiac pacemakers and defibrillators. The arrival of EluPro signals a transformative leap in the $600 million U.S. implantable electronic device protection market, presenting an advanced solution where there was previously a significant unmet need. For years, the medical community has been seeking methods to enhance the safety and longevity of cardiac implant patients, particularly in battling post-su...
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
